A flow cytometry-based assay to assess RSV-specific neutralizing antibody is reproducible, efficient and accurate.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  JIM - Journal of Immunological Methods

• Publication date

  2010-10-31

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.jim.2010.08.005PMID 20727896PMCID PMC2964415
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Human antibody titers to Epstein-Barr Virus (EBV) gp350 correlate with neutralization of infectivity better than antibody titers to EBV gp42 using a rapid flow cytometry-based EBV neutralization assay.

  2009cited by this paper
• A SARS DNA vaccine induces neutralizing antibody and cellular immune responses in healthy adults in a Phase I clinical trial

  2008cited by this paper
• A West Nile virus DNA vaccine induces neutralizing antibody in healthy adults during a phase 1 clinical trial.

  2007cited by this paper
• Viral and Host Factors in Human Respiratory Syncytial Virus Pathogenesis

  2007cited by this paper
• A rapid and quantitative assay for measuring antibody-mediated neutralization of West Nile virus infection.

  2006influential reference
• Human Immunodeficiency Virus Type 1 Neutralization Measured by Flow Cytometric Quantitation of Single-Round Infection of Primary Human T Cells

  2002cited by this paper
• Mechanisms of virus neutralization by antibody.

  2001cited by this paper
• Iduronic acid-containing glycosaminoglycans on target cells are required for efficient respiratory syncytial virus infection.

  2000cited by this paper
• Development of a humanized monoclonal antibody (MEDI-493) with potent in vitro and in vivo activity against respiratory syncytial virus.

  1997cited by this paper
• Primary respiratory syncytial virus infection in mice

  1988cited by this paper
• Microneutralization test for respiratory syncytial virus based on an enzyme immunoassay

  1985cited by this paper
• Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group, and maternal antibody level.

  1981cited by this paper
• Observations on Anti-Phage Sera. I: “The Percentage Law”

  1933cited by this paper

• Comparative assessment of four virus neutralization assays for detection of SARS-CoV-2 neutralizing antibodies.

  2025cites this paper
• Biology of human respiratory syncytial virus: Current perspectives in immune response and mechanisms against the virus

  2024cites this paper
• Virus neutralization assays for human respiratory syncytial virus using airway organoids

  2024cites this paper
• Development of a high-throughput flow cytometric neutralization assay to screen for human enterovirus A71 (EVA71) neutralizing antibodies.

  2023cites this paper
• Pseudovirus-Based Assays for the Measurement of Antibody-Mediated Neutralization of SARS-CoV-2.

  2022cites this paper
• Molecular Modeling Predicts Novel Antibody Escape Mutations in the Respiratory Syncytial Virus Fusion Glycoprotein

  2022cites this paper
• Molecular modeling predicts novel antibody escape mutations in respiratory syncytial virus fusion glycoprotein

  2022cites this paper
• Development and qualification of a fast, high-throughput and robust imaging-based neutralization assay for respiratory syncytial virus.

  2021cites this paper
• RSV neutralization assays - Use in immune response assessment.

  2021cites this paper
• Methods to Measure Antibody Neutralization of Live Human Coronavirus OC43

  2021cites this paper
• A comprehensive influenza reporter virus panel for high-throughput deep profiling of neutralizing antibodies

  2020cites this paper
• Structure of RVFV Gn and human monoclonal antibody R17

  2019cites this paper
• Neutralization mechanism of human monoclonal antibodies against Rift Valley fever virus

  2019cites this paper
• An optimized high-throughput fluorescence plate reader-based RSV neutralization assay.

  2018cites this paper
• Improving ability of RSV microneutralization assay to detect G-specific and cross-reactive neutralizing antibodies through immortalized cell line selection.

  2018cites this paper
• Infants Infected with Respiratory Syncytial Virus Generate Potent Neutralizing Antibodies that Lack Somatic Hypermutation

  2018cites this paper
• Development of a High-Throughput Respiratory Syncytial Virus Fluorescent Focus-Based Microneutralization Assay

  2017cites this paper
• A rapid, simple, and accurate plaque assay for human respiratory syncytial virus (HRSV).

  2017cites this paper
• RSV glycoprotein and genomic RNA dynamics reveal filament assembly prior to the plasma membrane

  2017cites this paper
• Discovery of a Prefusion Respiratory Syncytial Virus F-Specific Monoclonal Antibody That Provides Greater In Vivo Protection than the Murine Precursor of Palivizumab

  2017cites this paper
• A high-throughput neutralizing assay for antibodies and sera against hepatitis E virus

  2016cites this paper
• Pre-fusion F is absent on the surface of formalin-inactivated respiratory syncytial virus

  2016influential citation
• Characterization of a Prefusion-Specific Antibody That Recognizes a Quaternary, Cleavage-Dependent Epitope on the RSV Fusion Glycoprotein

  2015cites this paper
• Mucosal delivery of a vectored RSV vaccine is safe and elicits protective immunity in rodents and nonhuman primates

  2015cites this paper
• Efficacy of a virus-vectored vaccine against human and bovine respiratory syncytial virus infections

  2015cites this paper
• Comparison of viral titers and cytokine profiles between males and females at risk of kaposi's sarcoma development

  2014cites this paper
• Proof of principle for epitope-focused vaccine design

  2014cites this paper
• Rapid detection of neutralizing antibodies against bovine viral diarrhoea virus using quantitative high-content screening.

  2014cites this paper
• Loop mediated isothermal amplification to detect respiratory syncytial virus in respiratory specimens

  2014cites this paper
• Immunogenicity of Novel Mumps Vaccine Candidates Generated by Genetic Modification

  2013cites this paper
• A neutralization assay for respiratory syncytial virus using a quantitative PCR-based endpoint assessment

  2013cites this paper
• Structure of RSV Fusion Glycoprotein Trimer Bound to a Prefusion-Specific Neutralizing Antibody

  2013cites this paper
• Recent Advances in Diagnosis, Prevention, and Treatment of Human Respiratory Syncytial Virus

  2013cites this paper
• Development of a simple, rapid, sensitive, high-throughput luciferase reporter based microneutralization test for measurement of virus neutralizing antibodies following Respiratory Syncytial Virus vaccination and infection.

  2013cites this paper
• Translational sciences approach to RSV vaccine development

  2013cites this paper
• Role of Neutralizing Antibodies in Adults With Community-Acquired Pneumonia by Respiratory Syncytial Virus

  2012cites this paper
• Cimicifuga foetida L. inhibited human respiratory syncytial virus in HEp-2 and A549 cell lines.

  2012influential citation
• Antiviral effect of cimicifugin from Cimicifuga foetida against human respiratory syncytial virus.

  2012cites this paper
• An improved respiratory syncytial virus neutralization assay based on the detection of green fluorescent protein expression and automated plaque counting

  2012cites this paper
• Sheng-Ma-Ge-Gen-Tang (Shoma-kakkon-to) inhibited cytopathic effect of human respiratory syncytial virus in cell lines of human respiratory tract.

  2011cites this paper
• Liu-He-Tang inhibited plaque formation by human respiratory syncytial virus infection in cell lines of the human respiratory tract.

  2011cites this paper
• Design and characterization of epitope-scaffold immunogens that present the motavizumab epitope from respiratory syncytial virus.

  2011cites this paper
• Structure of a Major Antigenic Site on the Respiratory Syncytial Virus Fusion Glycoprotein in Complex with Neutralizing Antibody 101F

  2010cites this paper